Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase 2021-12-24 16:30
Convidecia™ Phase III Results Published in The Lancet 2021-12-24 15:28
Novavax and SK bioscience Expand Manufacturing Agreement 2021-12-24 07:30
Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice 2021-12-23 22:05
Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility' 2021-12-23 20:00
Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets 2021-12-23 16:23
Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma 2021-12-23 09:00
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China 2021-12-23 07:44
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies 2021-12-23 05:54
Origin Agritech Developing Nutrition Enhanced Corn Using CRISPR Gene Editing 2021-12-23 01:15
AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in Congenital Myotonic Dystrophy 2021-12-22 21:00
Angel Yeast Invests in New Enzyme Project Capable of 5,000 Tons Annual Production Output 2021-12-22 20:00
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines 2021-12-22 19:00
HKU teams develop the first anti-COVID-19 stainless steel 2021-12-22 18:09
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine 2021-12-22 09:31
EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization 2021-12-21 21:15
The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level 2021-12-21 08:04
European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine 2021-12-21 03:28
Henlius' anti-PD-1 mAb MRCT achieved 15.38 months OS in first-line treatment of SCLC, reducing the risk of death by 38% of the overall population 2021-12-20 22:00
I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization 2021-12-20 21:00
1 202 203 204 205 206 453